HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation CyclophosphamideLeo Luznik, Ephraim J. Fuchs, Paul V. O’Donnell et al.|Biology of Blood and Marrow Transplantation|2008Cited by 1.9k
Hodgkin lymphoma: A review and update on recent progressSatish Shanbhag, Richard F. Ambinder|CA A Cancer Journal for Clinicians|2017Cited by 479
Autologous Bone Marrow Transplantation in Patients with Acute Nonlymphocytic Leukemia, Using ex Vivo Marrow Treatment with 4-HydroperoxycyclophosphamideAndrew M. Yeager, John R. Wingard, Rein Saral et al.|New England Journal of Medicine|1986Cited by 441
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamideShannon R. McCurdy, Yvette L. Kasamon, Jennifer A. Kanakry et al.|Blood|2015Cited by 299
Comparison of Outcomes of HLA-Matched Related, Unrelated, or HLA-Haploidentical Related Hematopoietic Cell Transplantation following Nonmyeloablative Conditioning for Relapsed or Refractory Hodgkin LymphomaLauri M. Burroughs, David G. Maloney, Paul V. O’Donnell et al.|Biology of Blood and Marrow Transplantation|2008Cited by 264